Titre : Sondes d'acide nucléique

Sondes d'acide nucléique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Platelet Transfusion
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sondes d'acide nucléique : Questions médicales les plus fréquentes", "headline": "Sondes d'acide nucléique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sondes d'acide nucléique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-17", "dateModified": "2025-05-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sondes d'acide nucléique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Sondes moléculaires", "url": "https://questionsmedicales.fr/mesh/D015335", "about": { "@type": "MedicalCondition", "name": "Sondes moléculaires", "code": { "@type": "MedicalCode", "code": "D015335", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Éléments antisens (génétique)", "alternateName": "Antisense Elements (Genetics)", "url": "https://questionsmedicales.fr/mesh/D016375", "about": { "@type": "MedicalCondition", "name": "Éléments antisens (génétique)", "code": { "@type": "MedicalCode", "code": "D016375", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ADN antisens", "alternateName": "DNA, Antisense", "url": "https://questionsmedicales.fr/mesh/D016373", "about": { "@type": "MedicalCondition", "name": "ADN antisens", "code": { "@type": "MedicalCode", "code": "D016373", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.200" } } }, { "@type": "MedicalWebPage", "name": "Oligonucléotides antisens", "alternateName": "Oligonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D016376", "about": { "@type": "MedicalCondition", "name": "Oligonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D016376", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.640" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Oligodésoxyribonucléotides antisens", "alternateName": "Oligodeoxyribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020319", "about": { "@type": "MedicalCondition", "name": "Oligodésoxyribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020319", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.640.640" } } } ] }, { "@type": "MedicalWebPage", "name": "Oligodésoxyribonucléotides antisens", "alternateName": "Oligodeoxyribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020319", "about": { "@type": "MedicalCondition", "name": "Oligodésoxyribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020319", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.640.640" } } }, { "@type": "MedicalWebPage", "name": "ARN antisens", "alternateName": "RNA, Antisense", "url": "https://questionsmedicales.fr/mesh/D016372", "about": { "@type": "MedicalCondition", "name": "ARN antisens", "code": { "@type": "MedicalCode", "code": "D016372", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.760" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Oligoribonucléotides antisens", "alternateName": "Oligoribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020320", "about": { "@type": "MedicalCondition", "name": "Oligoribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020320", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.760.645" } } } ] }, { "@type": "MedicalWebPage", "name": "Oligoribonucléotides antisens", "alternateName": "Oligoribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020320", "about": { "@type": "MedicalCondition", "name": "Oligoribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020320", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.760.645" } } } ] }, { "@type": "MedicalWebPage", "name": "Sondes d'ADN", "alternateName": "DNA Probes", "url": "https://questionsmedicales.fr/mesh/D015342", "about": { "@type": "MedicalCondition", "name": "Sondes d'ADN", "code": { "@type": "MedicalCode", "code": "D015342", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ADN complémentaire", "alternateName": "DNA, Complementary", "url": "https://questionsmedicales.fr/mesh/D018076", "about": { "@type": "MedicalCondition", "name": "ADN complémentaire", "code": { "@type": "MedicalCode", "code": "D018076", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.260" } } }, { "@type": "MedicalWebPage", "name": "Amorces ADN", "alternateName": "DNA Primers", "url": "https://questionsmedicales.fr/mesh/D017931", "about": { "@type": "MedicalCondition", "name": "Amorces ADN", "code": { "@type": "MedicalCode", "code": "D017931", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.600" } } }, { "@type": "MedicalWebPage", "name": "Sondes d'ADN spécifiques des gènes HLA", "alternateName": "DNA Probes, HLA", "url": "https://questionsmedicales.fr/mesh/D015343", "about": { "@type": "MedicalCondition", "name": "Sondes d'ADN spécifiques des gènes HLA", "code": { "@type": "MedicalCode", "code": "D015343", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.615" } } }, { "@type": "MedicalWebPage", "name": "Sondes d'ADN spécifiques du VPH", "alternateName": "DNA Probes, HPV", "url": "https://questionsmedicales.fr/mesh/D015344", "about": { "@type": "MedicalCondition", "name": "Sondes d'ADN spécifiques du VPH", "code": { "@type": "MedicalCode", "code": "D015344", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.620" } } } ] }, { "@type": "MedicalWebPage", "name": "Sondes oligonucléotidiques", "alternateName": "Oligonucleotide Probes", "url": "https://questionsmedicales.fr/mesh/D015345", "about": { "@type": "MedicalCondition", "name": "Sondes oligonucléotidiques", "code": { "@type": "MedicalCode", "code": "D015345", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.650" } } }, { "@type": "MedicalWebPage", "name": "Sondes d'ARN", "alternateName": "RNA Probes", "url": "https://questionsmedicales.fr/mesh/D015347", "about": { "@type": "MedicalCondition", "name": "Sondes d'ARN", "code": { "@type": "MedicalCode", "code": "D015347", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.825" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ARN complémentaire", "alternateName": "RNA, Complementary", "url": "https://questionsmedicales.fr/mesh/D018075", "about": { "@type": "MedicalCondition", "name": "ARN complémentaire", "code": { "@type": "MedicalCode", "code": "D018075", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.825.840" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Sondes d'acide nucléique", "alternateName": "Nucleic Acid Probes", "code": { "@type": "MedicalCode", "code": "D015341", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Na Li", "url": "https://questionsmedicales.fr/author/Na%20Li", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, P. R. China." } }, { "@type": "Person", "name": "Ru Sun", "url": "https://questionsmedicales.fr/author/Ru%20Sun", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Material Science, Soochow University, 199 Ren'Ai Road, 215123, Suzhou, China." } }, { "@type": "Person", "name": "Yu-Jie Xu", "url": "https://questionsmedicales.fr/author/Yu-Jie%20Xu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, 215123, Suzhou, China." } }, { "@type": "Person", "name": "Jian-Feng Ge", "url": "https://questionsmedicales.fr/author/Jian-Feng%20Ge", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Material Science, Soochow University, 199 Ren'Ai Road, 215123, Suzhou, China. ge_jianfeng@hotmail.com." } }, { "@type": "Person", "name": "Bo Tang", "url": "https://questionsmedicales.fr/author/Bo%20Tang", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, P. R. China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation.", "datePublished": "2023-01-20", "url": "https://questionsmedicales.fr/article/36599813", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ejh.13925" } }, { "@type": "ScholarlyArticle", "name": "Systematic reviews on platelet transfusions: Is there unnecessary duplication of effort? A scoping review.", "datePublished": "2022-12-01", "url": "https://questionsmedicales.fr/article/36454598", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/vox.13387" } }, { "@type": "ScholarlyArticle", "name": "The safety of ABO minor incompatible platelets transfusions using a rapid infuser.", "datePublished": "2024-02-01", "url": "https://questionsmedicales.fr/article/38299721", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/trf.17739" } }, { "@type": "ScholarlyArticle", "name": "Therapeutic Efficacy of Platelet Transfusion and Analysis of Influencing Factors in 364 patients.", "datePublished": "2023-02-09", "url": "https://questionsmedicales.fr/article/36758527", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000529542" } }, { "@type": "ScholarlyArticle", "name": "Platelet transfusion practice pattern before and after implementation of a local restrictive transfusion protocol in a neonatal intensive care unit.", "datePublished": "2022-11-12", "url": "https://questionsmedicales.fr/article/36369934", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/trf.17184" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Utilisations spécialisées de produits chimiques", "item": "https://questionsmedicales.fr/mesh/D020313" }, { "@type": "ListItem", "position": 4, "name": "Produits chimiques de laboratoire", "item": "https://questionsmedicales.fr/mesh/D019995" }, { "@type": "ListItem", "position": 5, "name": "Sondes moléculaires", "item": "https://questionsmedicales.fr/mesh/D015335" }, { "@type": "ListItem", "position": 6, "name": "Sondes d'acide nucléique", "item": "https://questionsmedicales.fr/mesh/D015341" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sondes d'acide nucléique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sondes d'acide nucléique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sondes d'acide nucléique", "description": "Comment les sondes d'acide nucléique sont-elles utilisées en diagnostic ?\nQuelles maladies peuvent être détectées avec des sondes ?\nQuel est le principe de fonctionnement des sondes ?\nLes sondes peuvent-elles détecter des mutations génétiques ?\nQuel type d'échantillons est utilisé pour les sondes ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Transfusion&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique révèlent-elles des symptômes ?\nPeut-on utiliser des sondes pour surveiller des symptômes ?\nLes sondes peuvent-elles aider à prédire des symptômes ?\nLes sondes sont-elles liées à des symptômes spécifiques ?\nComment les sondes aident-elles à comprendre les symptômes ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Transfusion&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique jouent-elles un rôle préventif ?\nComment les sondes aident-elles à la prévention des maladies ?\nPeut-on utiliser des sondes pour la vaccination ?\nLes sondes peuvent-elles détecter des infections précoces ?\nLes sondes sont-elles utilisées dans les programmes de santé publique ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Transfusion&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique sont-elles utilisées en traitement ?\nComment les sondes influencent-elles le choix du traitement ?\nPeut-on développer des traitements basés sur des sondes ?\nLes sondes aident-elles à surveiller l'efficacité des traitements ?\nLes sondes sont-elles utilisées dans les essais cliniques ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Transfusion&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique peuvent-elles causer des complications ?\nQuelles complications peuvent survenir avec des sondes ?\nLes sondes peuvent-elles entraîner des effets secondaires ?\nComment minimiser les complications liées aux sondes ?\nLes sondes sont-elles fiables pour éviter des complications ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Transfusion&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sondes d'acide nucléique", "description": "Quels facteurs de risque sont associés à l'utilisation des sondes ?\nLes sondes sont-elles influencées par des facteurs environnementaux ?\nL'âge est-il un facteur de risque pour l'utilisation des sondes ?\nLes habitudes de vie influencent-elles les résultats des sondes ?\nLes sondes sont-elles affectées par des facteurs génétiques ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Transfusion&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment les sondes d'acide nucléique sont-elles utilisées en diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'identifier des séquences génétiques spécifiques liées à des maladies." } }, { "@type": "Question", "name": "Quelles maladies peuvent être détectées avec des sondes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont utilisées pour détecter des infections virales, bactériennes et des cancers." } }, { "@type": "Question", "name": "Quel est le principe de fonctionnement des sondes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elles se lient spécifiquement à des séquences cibles, permettant leur détection par hybridation." } }, { "@type": "Question", "name": "Les sondes peuvent-elles détecter des mutations génétiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines sondes sont conçues pour identifier des mutations spécifiques dans l'ADN." } }, { "@type": "Question", "name": "Quel type d'échantillons est utilisé pour les sondes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des échantillons de sang, de tissus ou de fluides corporels peuvent être analysés." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique révèlent-elles des symptômes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles détectent des séquences génétiques, pas des symptômes cliniques." } }, { "@type": "Question", "name": "Peut-on utiliser des sondes pour surveiller des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, en surveillant des biomarqueurs associés à des symptômes spécifiques." } }, { "@type": "Question", "name": "Les sondes peuvent-elles aider à prédire des symptômes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent indiquer un risque accru de maladies, mais pas de symptômes immédiats." } }, { "@type": "Question", "name": "Les sondes sont-elles liées à des symptômes spécifiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont liées à des maladies, qui peuvent avoir des symptômes variés." } }, { "@type": "Question", "name": "Comment les sondes aident-elles à comprendre les symptômes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elles aident à identifier les causes génétiques sous-jacentes des symptômes observés." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique jouent-elles un rôle préventif ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, en permettant le dépistage précoce de maladies génétiques ou infectieuses." } }, { "@type": "Question", "name": "Comment les sondes aident-elles à la prévention des maladies ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'identifier les individus à risque et de mettre en place des mesures préventives." } }, { "@type": "Question", "name": "Peut-on utiliser des sondes pour la vaccination ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent aider à développer des vaccins en identifiant des cibles immunogènes." } }, { "@type": "Question", "name": "Les sondes peuvent-elles détecter des infections précoces ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont efficaces pour détecter des infections à un stade précoce." } }, { "@type": "Question", "name": "Les sondes sont-elles utilisées dans les programmes de santé publique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont intégrées dans des programmes de dépistage et de surveillance épidémiologique." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique sont-elles utilisées en traitement ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne sont pas des traitements, mais aident à guider les choix thérapeutiques." } }, { "@type": "Question", "name": "Comment les sondes influencent-elles le choix du traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elles identifient des cibles spécifiques, permettant des thérapies ciblées adaptées." } }, { "@type": "Question", "name": "Peut-on développer des traitements basés sur des sondes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements peuvent être développés pour cibler des séquences spécifiques." } }, { "@type": "Question", "name": "Les sondes aident-elles à surveiller l'efficacité des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être utilisées pour évaluer la réponse au traitement au niveau moléculaire." } }, { "@type": "Question", "name": "Les sondes sont-elles utilisées dans les essais cliniques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent utilisées pour évaluer des biomarqueurs dans les essais cliniques." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique peuvent-elles causer des complications ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont généralement sûres, mais des erreurs de diagnostic peuvent entraîner des complications." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des sondes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des faux positifs ou négatifs, affectant le traitement." } }, { "@type": "Question", "name": "Les sondes peuvent-elles entraîner des effets secondaires ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles n'ont pas d'effets secondaires directs, mais des erreurs peuvent avoir des conséquences." } }, { "@type": "Question", "name": "Comment minimiser les complications liées aux sondes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "En utilisant des protocoles de test rigoureux et en validant les résultats obtenus." } }, { "@type": "Question", "name": "Les sondes sont-elles fiables pour éviter des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont généralement fiables, mais leur précision dépend de la qualité des échantillons." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés à l'utilisation des sondes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux de maladies génétiques ou infectieuses." } }, { "@type": "Question", "name": "Les sondes sont-elles influencées par des facteurs environnementaux ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme l'exposition à des agents pathogènes peuvent influencer les résultats." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour l'utilisation des sondes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies détectées par sondes sont plus fréquentes chez les personnes âgées." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles les résultats des sondes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme peuvent affecter la santé et les résultats des tests." } }, { "@type": "Question", "name": "Les sondes sont-elles affectées par des facteurs génétiques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des variations génétiques peuvent influencer la sensibilité et la spécificité des sondes." } } ] } ] }

Sources (7102 au total)

Systematic reviews on platelet transfusions: Is there unnecessary duplication of effort? A scoping review.

Platelet transfusions are used across multiple patient populations to prevent and correct bleeding. This scoping review aimed to map the currently available systematic reviews (SRs) and evidence-based... A systematic literature search was conducted in seven databases for SRs on effectiveness (including dose and timing, transfusion trigger and ratio to other blood products), production modalities and d... We identified 110 SRs. The majority focused on clinical effectiveness, including prophylactic or therapeutic transfusions compared to no platelet transfusion (34 SRs), prophylactic compared to therape... An interactive evidence map of SRs and evidence-based guidelines in the field of platelet transfusion has been developed and identified multiple reviews. This work serves as a tool for researchers loo...

The safety of ABO minor incompatible platelets transfusions using a rapid infuser.

Administering platelets through a rapid infuser is proven to be safe. However, the clinical significance of infusing ABO-incompatible platelets with red blood cells (RBCs) in a rapid infuser remains u... Seven in vitro studies were performed including five cases (type A RBCs and type O platelets) and two controls (type A RBCs and platelets). Anti-A titers were measured in platelet units. An RBC unit a... The post-mix DAT was positive for IgG in all test samples (5/5), and weakly positive for complement in 3/5. The changes in free Hb in test cases between measured and calculated post-mix spanned -2.2 t... Our study suggested that mixing ABO-incompatible platelets with RBCs in a rapid infuser does not induce in vitro hemolysis. These findings support the use of rapid infusers regardless of platelet comp...

Therapeutic Efficacy of Platelet Transfusion and Analysis of Influencing Factors in 364 patients.

The aims of this study were to observe the therapeutic effect of platelet (PLT) transfusion and to analyze influencing factors for the sake of providing useful clues for improving the efficacy of PLT ... Included in this study were patients who received PLT transfusion in the affiliated hospital of Nantong University. Patients' sex, age, height, weight, PLT transfusion status, and 20-24-h PLT count be... A total of 364 patients received 1,060 PLT transfusions, including 728 successful transfusions and 332 unsuccessful transfusions. When the patients were grouped according to different etiologies, sign... To reduce PTR, multiple factors should be considered comprehensively when PLT transfusion therapy is to be implemented in clinical practice. PLT antibody is the main immune factor causing PTR....

Platelet transfusion practice pattern before and after implementation of a local restrictive transfusion protocol in a neonatal intensive care unit.

Following the results of the PlaNeT-2 randomized controlled trial showing decreased morbidity and mortality in neonates transfused at a threshold of 25 versus 50 × 10... Prospective observational cohort chart-review study comparing all neonates consecutively admitted to the NICU during two 5-months periods: 2013 (before; N = 401) versus 2021 (after; N = 402). Possible... Mean (± standard deviation) gestational age and birth weight were 34.9 ± 4.2 weeks and 2.5 ± 1.0 kg, respectively. In 2021, 5.0% were platelet-transfused versus 9.2% in 2013 (p = .027). Platelet trans... Restrictive local transfusion thresholds in a NICU decreased the proportion of platelet-transfused neonates by 46% and reduced donor exposure in transfused patients....

Two-year outcomes following a randomised platelet transfusion trial in preterm infants.

Assess mortality and neurodevelopmental outcomes at 2 years of corrected age in children who participated in the PlaNeT-2/MATISSE (Platelets for Neonatal Transfusion - 2/Management of Thrombocytopenia... Randomised clinical trial, enrolling from June 2011 to August 2017. Follow-up was complete by January 2020. Caregivers were not blinded; however, outcome assessors were blinded to treatment group.... 43 level II/III/IV neonatal intensive care units (NICUs) across UK, Netherlands and Ireland.... 660 infants born at less than 34 weeks' gestation with platelet counts less than 50×10... Infants were randomised to undergo a platelet transfusion at platelet count thresholds of 50×10... Our prespecified long-term follow-up outcome was a composite of death or neurodevelopmental impairment (developmental delay, cerebral palsy, seizure disorder, profound hearing or vision loss) at 2 yea... Follow-up data were available for 601 of 653 (92%) eligible participants. Of the 296 infants assigned to the higher threshold group, 147 (50%) died or survived with neurodevelopmental impairment, as c... Infants randomised to a higher platelet transfusion threshold of 50×10... ISRCTN87736839....

Aged versus fresh autologous platelet transfusion in a two-hit healthy volunteer model of transfusion-related acute lung injury.

Transfusion-related acute lung injury (TRALI) is a severe complication of blood transfusion that is thought of as a two-hit event: first the underlying patient condition (e.g., sepsis), and then the t... In a randomized controlled trial, 18 healthy male volunteers received a first hit of experimental endotoxemia (2 ng/kg lipopolysaccharide), and a second hit of fresh (2-day old) or aged (7-day old) au... All subjects reacted adequately to lipopolysaccharide infusion and satisfied SIRS criteria (increased pulse [>90/min] and temperature [>38°C]). There were no differences between the saline, fresh, and... In a human endotoxemia model of autologous platelet transfusion, with an adequate first hit and platelet storage lesion, transfusion of 7-day-old PC does not increase pulmonary inflammation compared w...

A randomized cross-over study of cryopreserved platelets in prophylactic transfusions of thrombocytopenic patients.

The short shelf-life of liquid-stored platelets (LP) at 20-24°C poses shortage and wastage challenges. Cryopreserved platelets have significantly extended shelf-life, and were safe and efficacious for... We performed a phase 1b/2a randomized cross-over study comparing the safety and efficacy of cryopreserved buffy coat-derived pooled platelets (CP) to LP in the prophylactic transfusions of thrombocyto... A total of 18 adults were randomly assigned 1:1 to CP and LP for their first thrombocytopenic period (TP) of up to 28-days. A total of 14 crossed over to the other platelet-arm for the second TP. Over... During shortages, CP may supplement LP in prophylactic transfusions of thrombocytopenic patients....